Intra-patient dose escalation in Ewing’s sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review

BACKGROUND: Data suggests that males experience less toxicity and poorer survival than females treated for Ewing’s sarcoma. We instituted an intra-patient dose escalation (DE) policy with Vincristine/Doxorubicin/Cyclophosphamide (VDC) alternating with Ifosfamide/Etoposide (IE) based on hematological...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lewin, Jeremy, Wieringa, Samantha, Collins, Marnie, Desai, Jayesh, Orme, Lisa, Lingaratnam, Senthil, Thomas, David M
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3866566/
https://ncbi.nlm.nih.gov/pubmed/24321600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2045-3329-3-15
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars